Drd2em1(cre)Phsh
Endonuclease-mediated Allele Detail
|
Symbol: |
Drd2em1(cre)Phsh |
Name: |
dopamine receptor D2; endonuclease-mediated mutation 1, Minoru Narita |
MGI ID: |
MGI:7434696 |
Synonyms: |
D2-cre, Drd2tm1(cre)Phsh |
Gene: |
Drd2 Location: Chr9:49251927-49319477 bp, + strand Genetic Position: Chr9, 26.72 cM
|
Alliance: |
Drd2em1(cre)Phsh page
|
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Endonuclease-mediated (Recombinase) |
Mutation: |
|
Insertion
|
|
|
Drd2em1(cre)Phsh expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Drd2 (MGI:94924) |
|
|
|
|
Using CRISPR/Cas9 technology, cre coding sequence was inserted into the Drd2 gene. (J:333162)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Drd2
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Drd2 Mutation: |
70 strains or lines available
|
|
Original: |
J:333162 Sato D, et al., Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens. Mol Brain. 2022 Feb 16;15(1):17 |
All: |
1 reference(s) |
|